Compare ORGO & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | QUIK |
|---|---|---|
| Founded | 1985 | 1988 |
| Country | United States | United States |
| Employees | N/A | 51 |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.0M | 196.7M |
| IPO Year | 2016 | 1997 |
| Metric | ORGO | QUIK |
|---|---|---|
| Price | $1.03 | $8.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.00 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 750.4K | 159.7K |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | $20,112,000.00 |
| Revenue This Year | N/A | $73.33 |
| Revenue Next Year | $37.55 | $16.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $0.93 | $5.28 |
| 52 Week High | $7.08 | $24.33 |
| Indicator | ORGO | QUIK |
|---|---|---|
| Relative Strength Index (RSI) | 26.71 | 30.07 |
| Support Level | N/A | $8.72 |
| Resistance Level | $2.57 | $9.27 |
| Average True Range (ATR) | 0.08 | 0.43 |
| MACD | -0.01 | -0.16 |
| Stochastic Oscillator | 23.06 | 0.98 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.